title: Reduced plasma level of diazepam-binding inhibitor (DBI) in patients with morbid obesity.
authors.affiliation: Department of Clinical Endocrinology, Medical University of Lodz, ul. Sterlinga 3, 91-425, Lodz, Poland, agnieszka.siejka@umed.lodz.pl.
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Siejka
authors.forename: Joanna
authors.initials: J
authors.lastname: Jankiewicz-Wika
authors.forename: Henryk
authors.initials: H
authors.lastname: Stępień
authors.forename: Jolanta
authors.initials: J
authors.lastname: Fryczak
authors.forename: Jacek
authors.initials: J
authors.lastname: Świętosławski
authors.forename: Jan
authors.initials: J
authors.lastname: Komorowski
mesh_terms: D000328:Adult; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D026261:Diazepam Binding Inhibitor / Q000097:blood* / Q000494:pharmacology; D005260:Female; D018149:Glucose Intolerance / Q000150:complications; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009479:Neuropeptides / Q000097:blood / Q000494:pharmacology; D009767:Obesity, Morbid / Q000097:blood*; D010446:Peptide Fragments / Q000097:blood / Q000494:pharmacology; D010865:Pilot Projects; D054411:Receptors, Leptin / Q000097:blood
chemical_list: D026261:Diazepam Binding Inhibitor; D007004:Hypoglycemic Agents; D009479:Neuropeptides; D010446:Peptide Fragments; D054411:Receptors, Leptin; C067529:diazepam binding inhibitor (33-50)